Second, MYC transcriptional activation through phospho-STAT3 and RelA/NF-κB mediates T cell receptor-independent downstream signalling from activated CD28 that leads to inflammatory T cell responses in MS (Figure 3C) (Kunkl et al., 2019). Here, MYC is linked to myeloid sarcoma.